New findings into conquering influenza

Reseachers from the University of Melbourne and The Walter and Eliza Hall Institute (WEHI) have discovered a new protein that protects against viral infections such as influenza.

As spreads through the northern hemisphere winter, Dr Linda Wakim and her colleagues in the Laboratory of Professor Jose Villadangos from the Department of Biochemistry and Molecular Biology, and the Department of Microbiology and Immunology, believe they have a new clue to why some people fight infections better than others.

The lab has been investigating the 'defensive devices' contained within the T-cells that are located on exposed body surfaces such as skin and mucosal surfaces to ward off infection. T-cells detect cells infected with viruses and kill them before the virus can reproduce within the infected cell and spread to other cells.

Researchers found these cells contain the protein IFITM3 and this makes them more resistant to such as Influenza. The findings have been published in .

"If we learn how to increase the number and longevity of T-cells expressing IFITM3, this could lead to improved vaccines that promote the generation of more resistant T-cells able to provide the greatest protection, for longer." Professor Villadangos said.

Dr Wakim said "We are currently trying to understand why some T-cells and not others express this protective molecule. Probably they encounter some form of (a cytokine, or a surface molecule) in the tissues where they lodge, which induces the expression of IFITM3. If we identify these , we may be able to include them in future vaccines."

Related Stories

Recommended for you

AAPM: Platelet-rich plasma offers short-term benefit

date 1 hour ago

(HealthDay)—For patients with facet joint arthropathy, platelet-rich plasma (PRP) has a short-term positive impact, according to a study presented at the annual meeting of the American Academy of Pain Medicine, ...

Brittle bone disease: Drug research offers hope

date 5 hours ago

New research at the University of Michigan offers evidence that a drug being developed to treat osteoporosis may also be useful for treating osteogenesis imperfecta or brittle bone disease, a rare but potentially debilitating ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.